Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

JAK inhibitors are effective and safe for treating severe alopecia areata.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Tofacitinib treatment for hair loss may worsen acne.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Topical JAK inhibitors may help treat hair loss.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.